Next |
home / stock / sva / sva message board
Subject | By | Source | When |
---|---|---|---|
$SVA Sinovac Biotech Ltd | mick | investorshub | 04/30/2023 9:28:53 PM |
Sinovac ndert Plan fr Aktionrsrechte Business Wire | mick | investorshub | 04/15/2023 3:47:19 PM |
Recent $SVA News | mick | investorshub | 04/15/2023 3:47:11 PM |
$SVA Sinovac Biotech Ltd | mick | investorshub | 04/15/2023 3:46:37 PM |
$SVA Sinovac Biotech Ltd | mick | investorshub | 02/27/2023 1:07:56 AM |
$SVA http://www.sinovac.com/ | mick | investorshub | 02/21/2023 11:46:28 PM |
SINOVAC Reports Unaudited First Half of 2022 Financial | mick | investorshub | 02/21/2023 11:40:25 PM |
FORM TYPE RECEIVED PERIOD END DATE REPORT | mick | investorshub | 02/21/2023 11:39:55 PM |
$SVA Sinovac Biotech Ltd | mick | investorshub | 02/21/2023 11:39:04 PM |
$SVA Sinovac Biotech Ltd | mick | investorshub | 02/21/2023 11:39:03 PM |
$SVA Latest News | mick | investorshub | 02/05/2023 11:20:53 PM |
https://www.otcmarkets.com/stock/$SVA/security | mick | investorshub | 02/05/2023 11:20:18 PM |
$SVA Sinovac Biotech Ltd | mick | investorshub | 02/05/2023 11:19:25 PM |
https://www.otcmarkets.com/stock/$SVA/disclosure | mick | investorshub | 12/18/2022 10:48:05 PM |
Recent $SVA News | mick | investorshub | 12/18/2022 10:47:27 PM |
Recent $SVA News | mick | investorshub | 12/18/2022 10:47:26 PM |
$SVA Sinovac Biotech Ltd | mick | investorshub | 12/18/2022 10:47:07 PM |
Recent $SVA News | mick | investorshub | 10/23/2022 5:53:34 PM |
https://www.nytimes.com/2020/12/25/health/turkey-brazil-sinovac-coronavirus-vacc | mick | investorshub | 10/23/2022 5:52:51 PM |
Contact: Stella Wang | mick | investorshub | 08/31/2022 10:40:25 PM |
News, Short Squeeze, Breakout and More Instantly...
Sinovac Biotech Ltd. Company Name:
SVA Stock Symbol:
NASDAQ Market:
--News Direct-- LONDON, Ontario; BOSTON, Massachusetts – TheNewswire – May 1, 2024, Sernova Corp. (“Sernova” or the “Corporation”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) a clinical-stage biotechnology company focused on the development of regenerativ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023. The annual r...
--News Direct-- Dr. Philip Toleikis to retire as of April 30, 2024 Cost savings from restructuring and strategic transformation anticipated to extend runway Board rebuild underway LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - April 25, 2024 –...